Gabapentin
Product Images NDC 50090-5322

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-5322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapentin 01)

Chemical structure diagram of Gabapentin, showing a cyclohexane ring with attached amino (CH2NH2) and carboxyl (CH2CO2H) functional groups.*

FDA Label Image

Figure 1 (Gabapentin 02)

A line graph illustrating the mean pain score over an 8-week period comparing placebo and Gabapentin 3,600 mg/day. The x-axis represents weeks from baseline through a 4-week dose titration period followed by a 4-week fixed dose period. The y-axis shows the mean pain score ranging from 0 to 10. Gabapentin shows a decline in mean pain score over time compared to the relatively stable score for placebo.*

FDA Label Image

Figure 2 (Gabapentin 03)

A line graph showing the mean pain score over seven weeks during a clinical study comparing placebo with two dosages of gabapentin (1,800 mg/day and 2,400 mg/day). The x-axis represents weeks including a 3-week dose titration period and a 4-week fixed dose period. The y-axis shows the mean pain score ranging from 0 to 10. The graph illustrates that gabapentin groups have a decreasing pain score over time, while the placebo group shows relatively stable pain scores.*

FDA Label Image

Figure 3 (Gabapentin 04)

A bar chart comparing percentages from two studies labeled Study 1 and Study 2. Each study contrasts placebo groups (PBO) in white bars with Gabapentin (GBP) groups in gray bars at different dosages (3,600 mg, 1,800 mg, and 2,400 mg). The chart includes significance markers for p-values below 0.01 and 0.001 above certain bars, representing statistical comparisons between PBO and GBP groups.*

FDA Label Image

Figure 4 (Gabapentin 05)

A scatter plot showing percentage difference versus daily dose in milligrams. The plot contains data points for three studies labeled a, b, and c, with daily doses ranging approximately from 600 mg to 1800 mg and percentage differences between about 2% and 22%. Study a is represented by black squares, study b by gray squares, and study c by white squares.*

FDA Label Image

Label Image (Lbl500905322)

Label for Gabapentin 400 mg capsules from A-S Medication Solutions, NDC 50090-5322. The label states each capsule contains 400 mg of gabapentin, USP. Storage instructions specify to keep at 77 degrees Fahrenheit. The package contains 90 capsules. Lot number and barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.